Efficacy of an Evernimicin (SCH27899) In Vitro and in an Animal Model of Lyme Disease
收藏PubMed Central2026-05-16 收录
下载链接：
https://pmc.ncbi.nlm.nih.gov/articles/PMC90397/
下载链接
链接失效反馈官方服务：
资源简介：
The MICs of evernimicin at which 90% of Borrelia burgdorferi patient isolates were inhibited ranged from 0.1 to 0.5 μg/ml. Evernimicin was as effective as ceftriaxone against B. burgdorferi in a murine model of experimental Lyme disease. As assessed by culturing the urinary bladders of infected C3H mice, no live Borrelia isolates were recoverable following antibiotic treatment.
提供机构：
American Society for Microbiology (ASM)
